UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

A groundbreaking annual injection designed to protect against Human Immunodeficiency Virus (HIV) has successfully ...

Early diagnosis and prompt antiretroviral therapy initiation are critical for children due to the rapid progression of HIV in ...

Modern HIV treatment offers remarkable outcomes. This guide explores essential first steps, treatment advances, support ...

A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in ...

South African researchers are making significant strides in validating traditional medicines for HIV treatment, highlighting ...

She urged the public to disregard the misinformation and avoid unnecessary panic, adding that NACA’S priority is to sustain ...